These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27085537)

  • 1. CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation.
    Danish HH; Heumann TR; Bradley KT; Switchenko J; Esiashvili N; Lechowicz MJ; Flowers CR; Khan MK
    Dermatol Ther (Heidelb); 2016 Jun; 6(2):251-63. PubMed ID: 27085537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique.
    Heumann TR; Esiashvili N; Parker S; Switchenko JM; Dhabbaan A; Goodman M; Lechowicz MJ; Flowers CR; Khan MK
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):183-91. PubMed ID: 25670538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
    Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with a single field rotational total skin electron irradiation technique for cutaneous T-cell lymphoma.
    Freeman CR; Suissa S; Shenouda G; Vuong T; Souhami L; Pla M; Podgorsak EB; Pla C
    Radiother Oncol; 1992 Jul; 24(3):155-62. PubMed ID: 1410569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
    Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy.
    Quiros PA; Kacinski BM; Wilson LD
    Cancer; 1996 May; 77(9):1912-7. PubMed ID: 8646693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
    Amber KT; Bloom R; Nouri K
    Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutional experience with a rotational total skin electron irradiation (RTSEI) technique-A three decade review (1981-2012).
    Evans MD; Hudon C; Podgorsak EB; Freeman CR
    Rep Pract Oncol Radiother; 2014 Mar; 19(2):120-34. PubMed ID: 24936331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases.
    Fauconneau A; Pham-Ledard A; Cappellen D; Frison E; Prochazkova-Carlotti M; Parrens M; Dalle S; Joly P; Viraben R; Franck F; Ingen-Housz-Oro S; Giacchero D; Jullié ML; Vergier B; Merlio JP; Beylot-Barry M
    Br J Dermatol; 2015 Jun; 172(6):1547-1554. PubMed ID: 25645336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
    Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
    Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total skin electron beam therapy for cutaneous T-cell lymphoma: a nationwide cohort study from Denmark.
    Lindahl LM; Kamstrup MR; Petersen PM; Wirén J; Fenger-Grøn M; Gniadecki R; Iversen L; Specht L
    Acta Oncol; 2011 Nov; 50(8):1199-205. PubMed ID: 21736502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of cutaneous lymphomas in Osaka, Japan (1988-1999) based on the European Organization for Research and Treatment of Cancer classification.
    Nagasawa T; Miwa H; Nakatsuka S; Itami S; Yoshikawa K; Aozasa K
    Am J Dermatopathol; 2000 Dec; 22(6):510-4. PubMed ID: 11190442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.
    Talpur R; Sui D; Gangar P; Dabaja BS; Duvic M
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):49-56. PubMed ID: 26702474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local radiation for cutaneous T-cell lymphoma other than mycosis fungoides and Sézary syndrome.
    Shikama N
    Chin Clin Oncol; 2019 Feb; 8(1):8. PubMed ID: 30180750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course.
    Wehkamp U; Oschlies I; Nagel I; Brasch J; Kneba M; Günther A; Klapper W; Weichenthal M
    J Cutan Pathol; 2015 Nov; 42(11):870-7. PubMed ID: 26053561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation.
    Maingon P; Truc G; Dalac S; Barillot I; Lambert D; Petrella T; Naudy S; Horiot JC
    Radiother Oncol; 2000 Jan; 54(1):73-8. PubMed ID: 10719702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
    Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
    J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal imbalances: a hallmark of tumour relapse in primary cutaneous CD30+ T-cell lymphoma.
    Prochazkova M; Chevret E; Beylot-Barry M; Sobotka J; Vergier B; Delaunay M; Turmo M; Ferrer J; Kuglik P; Merlio JP
    J Pathol; 2003 Nov; 201(3):421-9. PubMed ID: 14595754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management.
    Scarisbrick JJ
    Future Oncol; 2017 Nov; 13(27):2405-2411. PubMed ID: 28805086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.